Public Health
Moderna launches human trial for mRNA flu vaccine
Moderna Therapeutics is trialing an mRNA flu vaccine in humans and developing one to protect against seasonal influenza and COVID-19.
This bacteria can find a landmine
Bacteria that glow in the presence of a landmine may one day help save lives.
Will we finally get another human Lyme disease vaccine?
Pfizer and French vaccine maker Valneva are one step closer to bringing a human Lyme disease vaccine to market.
“LEGO-like” vaccine protects mice from COVID, SARS, MERS, and variants
Using a “chimeric” spike protein, researchers have immunized mice against multiple types of coronaviruses with one shot.
A new superbug strategy
Researchers at the University of Geneva have a new idea on how to stop superbugs: don’t kill them.
Series|
Just Might Work
Biohackers take aim at big pharma’s stranglehold on insulin
These biohackers plan to give away their instructions for how to make insulin for free.
We may have a new ally in the fight against dengue fever
A large trial has provided the best evidence yet that infecting mosquitoes with Wolbachia can help reduce dengue infections.
A virus "chimera" reveals new dengue targets
Using a flavivirus that only infects insects, Australian researchers can safely study more dangerous viruses.
Did the flu lose diversity during the pandemic?
After a record-low flu season, an entire clade of flu may be gone. If so, making vaccines may have become easier.
Series|
Just Might Work
Can we hack sugar to be healthy?
Is there such a thing as healthy sugar? Food scientists in Israel are hacking the sugar molecule itself – eliminating the need for subpar alternatives.